Drug Transporters and Multiple Drug Resistance in Pediatric Solid Tumors

Doriana Fruci, William C S Cho1, Valerio Nobili

  • 1Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong. williamcscho@gmail.com.

Current Drug Metabolism
|December 24, 2015
PubMed

Insights

Multidrug resistance (MDR) limits childhood cancer survival. This review explores ATP-binding cassette (ABC) transporters

Area of Science:

  • Pediatric Oncology
  • Cancer Pharmacology
  • Molecular Biology

Background:

  • Solid tumors represent a significant portion of childhood cancers.
  • Chemotherapy has improved outcomes, but multidrug resistance (MDR) remains a challenge.
  • ATP-binding cassette (ABC) transporters mediate MDR by increasing drug efflux from cancer cells.

Purpose of the Study:

  • To review the current literature on MDR and ABC transporters in common pediatric solid tumors.
  • To highlight the limited investigation of ABC transporter function in pediatric malignancies compared to adults.

Main Methods:

  • Literature review of existing studies on MDR and ABC transporters.
  • Focus on neuroblastoma, rhabdomyosarcoma, retinoblastoma, hepatoblastoma, and Wilms' tumor.

Main Results:

  • ABC transporters are key players in MDR across various pediatric solid tumors.
  • Evidence suggests differential roles and expression of ABC transporters in these cancers.
  • Limited data exists on the functional activity of these transporters in pediatric settings.

Conclusions:

  • Understanding ABC transporter roles is crucial for overcoming MDR in pediatric cancers.
  • Further research into ABC transporter function in pediatric solid tumors is warranted.
  • Targeting ABC transporters may offer novel therapeutic strategies for improving pediatric cancer survival.

Related Concept Videos

Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.5K
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
116
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
330
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
373
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
704
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
462